Results 181 to 190 of about 18,811 (223)

mGem: Opening Env and harnessing NK cell effector functions to eliminate HIV-1-infected cells. [PDF]

mBio
Richard J, Finzi A.
europepmc   +1 more source

Interface-Engineered Bi_0.5Sb_1.5Te₃/WSe₂ Heterostructures for Enhanced Thermoelectric Performance. [PDF]

Small
Giri K, Wang YL, Wu YT, Chen CH.
europepmc   +1 more source

pre-B細胞の増殖に関与する骨髄ストローマ細胞上の新規膜蛋白の遺伝子クローニング [PDF]

イシカワ, ジュン, 石川, 淳
core  

Mapping cellular vulnerability in Parkinson's disease using retro-AAVs and preformed α-synuclein fibrils. [PDF]

Transl Neurodegener
Geibl FF, Musa AAS, Dietrich L, Wolter H, Wokosin DL, Khudayberdiev S, Rust MB, Chen R, Dawson VL, Dawson TM, Oertel WH, Surmeier DJ, Henrich MT.   +12 more
europepmc   +1 more source

Post-Therapy Trajectories Following Brief Systemic Couple Therapy for Parents. [PDF]

Fam Process
Darwiche J, Nunes CE, Vowels L, Liekmeier E, Antonietti JP.   +4 more
europepmc   +1 more source

Biometric Evaluation of Baumann Skin Typing. [PDF]

Skin Res Technol
Delavar S, Firooz A, Nassiri Kashani M, Ahmad Nasrollahi S, Amiri F, Yazdanparast T.   +5 more
europepmc   +1 more source

[Optimized extraction of active components of <i>Paeonia lactiflora</i> and their antioxidant, anti-inflammatory and pigmentation-reducing effects for skin whitening]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Xu Q, Li W, Zhang X, Chen Y, Jiang Z, Li G, Yan M.   +6 more
europepmc   +1 more source

Loop-Mediated Isothermal Amplification (LAMP) Assay for the Detection of Bacterial Bovine Mastitis: A Systematic Review. [PDF]

Vet Med Sci
Jember TF, Westman ME, Pant SD, Ghorashi SA.   +3 more
europepmc   +1 more source

Lyophilised colourimetric LAMP for visual readout with dual colour indicators.

Analyst
Malpartida-Cardenas K, Stringer OW, Cavuto ML, Holmes A, Rodriguez-Manzano J.   +4 more
europepmc   +1 more source

HIV‐1 Vpu Antagonizes BST‐2 by Interfering Mainly with the Trafficking of Newly Synthesized BST‐2 to the Cell Surface [PDF]

Traffic, 2011
Bone marrow stromal cell antigen‐2 (BST‐2) inhibits human immunodeficiency virus type 1 (HIV‐1) release by cross‐linking nascent virions on infected cell surface. HIV‐1 Vpu is thought to antagonize BST‐2 by downregulating its surface levels via a mechanism that involves intracellular sequestration and lysosomal degradation.
Éric A Cohen, Mariana Gé Bego
exaly   +3 more sources